Kel­ly Mar­tin skips to a new CEO suite as his last biotech team rais­es the white flag

A few months af­ter step­ping away from the helm of a biotech with a flut­ter­ing pulse, ex-Elan chief Kel­ly Mar­tin is back in charge of an­oth­er drug com­pa­ny with its own set of is­sues to deal with.

Ra­dius Health in Waltham, MA an­nounced that the 61-year-old Mar­tin is step­ping in to re­place Jes­per Hoei­land, the No­vo vet who is now head­ed home to Den­mark. Hoei­land was brought in to lead the charge on a new os­teo­poro­sis drug mar­ket­ed as Tym­los, which hasn’t been go­ing well.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.